Vascular Pharmaceuticals, Inc. — Form D/A
Vascular Pharmaceuticals, Inc. of CARY, NC, a company, filed a Form D amendment with the SEC on 2013-11-19. The offering totals $16.0M, of which $9.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-11-19
- Form: D/A
- Accession: 0001557160-13-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.0M
- Amount sold: $9.0M
- Remaining: $7.0M
- Investors: 3
- Date of first sale: 2012-09-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-184519
Issuer
- Name: Vascular Pharmaceuticals, Inc.
- CIK: 0001557160
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 903 WALCOTT WAY, CARY, NC, 27519
- Phone: 919-345-7933
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Vaughn Kailian | Director | Chapel Hill, NC |
| Richard Kent | Director | London, X0 |
| Richard Shea | Director | Cary, NC |
| Richard Shea | Executive Officer | Cary, NC |
| Benjamin Rovinski | Director | Mendham, NJ |
| Ken Williams | Director | Burlington, NC |
| Elizabeth Stoner | Director | Cambridge, MA |
| David Clemmons | Director | Chapel Hill, NC |
| David Clemmons | Executive Officer | Chapel Hill, NC |
| Bonnie Layman | Executive Officer | Chapel Hill, NC |
Other filings by this issuer (5)
More